Clinical Trial Update: Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain [Phase 4]

View source ↗

Summary

Phase 4 real-world study of Mimeixin (oxycodone/naloxone sustained-release) for severe cancer pain; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Mimeixin (Oxycodone/naloxone sustained-release)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Opioid-Induced Constipation, Pain Cancer | Phase 4 | Status: NOT_YET_RECRUITING